EBS

EBS

USD

Emergent Biosolutions Inc. Common Stock

$10.090-0.120 (-1.175%)

Real-time Price

Healthcare
Drug Manufacturers - Specialty & Generic
United States

Price Chart

Loading Chart...

Key Metrics

Market Metrics
Company Fundamentals
Trading Stats

Market Metrics

Open

$10.210

High

$10.540

Low

$10.040

Volume

1.32M

Company Fundamentals

Market Cap

529.9M

Industry

Drug Manufacturers - Specialty & Generic

Country

United States

Trading Stats

Avg Volume

1.25M

Exchange

NYQ

Currency

USD

52-Week Range

Low $4.02Current $10.090High $13.41

Related News

GlobeNewswire

Emergent BioSolutions Reports Third Quarter 2025 Financial Results

Third Quarter 2025 Total Revenues of $231.1 million, above the high end of Q3 guidance by $21.0 millionThird Quarter 2025 Net Income of $51.2 million and Net Income Margin of 22%Third Quarter 2025 Gross Margin % of 54%

View more
Emergent BioSolutions Reports Third Quarter 2025 Financial Results